fbpx

Day

juli 28, 2018
SAN DIEGO and COPENHAGEN, Denmark, July 23, 2018 /PRNewswire/ — Dermtreat, a clinical-stage biopharmaceutical company focused on mucosal diseases, today announced treatment of the first patient in a Phase 2b clinical trial of Rivelin® Clobetasol patch (Rivelin®-CLO) for oral lichen planus (OLP). Rivelin-CLO is the first biodegradable oral adhesive patch designed for local delivery of clobetasol...

Nyheder

Hun fik så mange gode ideer når hun cyklede hjem fra arbejde
11. april 2019
Hjernens ’søhest’ skal sikre bedre behandling af psykiske lidelser
9. april 2019
Danske forskere vil spore hjerne-blodpropper 10.000 år tilbage
4. april 2019

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge